{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:36:13Z","timestamp":1789209373905,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.biomaterials.2011.07.021","type":"journal-article","created":{"date-parts":[[2011,8,14]],"date-time":"2011-08-14T12:54:10Z","timestamp":1313326450000},"page":"8029-8039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Accelerated healing of cutaneous leishmaniasis in non-healing BALB\/c mice using water soluble amphotericin B-polymethacrylic acid"],"prefix":"10.1016","volume":"32","author":[{"given":"Karina","family":"Corware","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kikkeri","family":"Naresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Shaunak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2011.07.021_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/09546630601159474","article-title":"Therapeutic options for cutaneous leishmaniasis","volume":"18","author":"Mahajan","year":"2007","journal-title":"J\u00a0Dermatol Treat"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Inf Dis"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib3","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/AAC.42.12.3092","article-title":"Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of AmB","volume":"42","author":"Frankenburg","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0924-8579(99)00133-8","article-title":"A\u00a0comparison of the activities of three AmB lipid formulations against experimental visceral and cutaneous leishmaniasis","volume":"13","author":"Yardley","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1128\/AAC.50.4.1238-1244.2006","article-title":"Nanodisk associated AmB clears L.\u00a0major cutaneous infection in susceptible BALB\/c mice","volume":"50","author":"Nelson","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib6","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4269\/ajtmh.2010.10-0171","article-title":"Lipsosomal AmB for treatment of cutaneous leishmania","volume":"83","author":"Wortmann","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib7","article-title":"Liposomal AmB treatment of cutaneous leishmaniasis due to L.\u00a0tropica","author":"Solomon","year":"2010","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib8","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1021\/bi00237a011","article-title":"One sided action of AmB on cholesterol containing membranes is determined by its association in media","volume":"30","author":"Bolard","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib9","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.36.11.2518","article-title":"Effects of aggregation and solvent on the toxicity of AmB to human erythrocytes","volume":"36","author":"Legrand","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/CMR.9.4.512","article-title":"Carrier effects on biological activity of AmB","volume":"9","author":"Brajtburg","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/oxfordjournals.jbchem.a002912","article-title":"Effect of aggregation of AmB on lysophosphatidylcholine micelles as related to its complex formation with cholesterol or ergosterol","volume":"129","author":"Kawabata","year":"2001","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/AAC.00870-07","article-title":"Comparison of the physicochemical, antifungal and toxic properties of two liposomal AmB products","volume":"52","author":"Olson","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/380971","article-title":"AmB treatment for Indian visceral leishmaniasis: conventional versus lipid formulations","volume":"38","author":"Sundar","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal AmB for visceral leishmaniasis in India","volume":"362","author":"Sundar","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib15","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1128\/AAC.47.8.2513-2517.2003","article-title":"Immuno-enhancement combined with AmB as treatment for experimental visceral leishmaniasis","volume":"47","author":"Murray","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to L.\u00a0major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis","volume":"85","author":"Stanley","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.271.5251.987","article-title":"Susceptibility to L.\u00a0major infection in IL-4 deficient mice","volume":"271","author":"Noben-Trauth","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20061886","article-title":"Sacks, D. CD4+CD25-Foxp3-Th1 cells are the source of IL-10 mediated immune suppression in chronic cutaneous leishmaniasis","volume":"204","author":"Anderson","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib20","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.194.10.1497","article-title":"The role of IL-10 in the persistence of L.\u00a0major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure","volume":"194","author":"Belkaid","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib21","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"IL-10 in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib22","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.4049\/jimmunol.179.4.2435","article-title":"Despite increased CD4+Foxp3+ cells within the infection site, BALB\/c IL-4 receptor-deficient mice reveal CD4+Foxp3- T-cells as a source of IL-10 in L.\u00a0major susceptibility","volume":"179","author":"Nagase","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib23","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/smll.201000765","article-title":"Polymethacrylic acid polymer hydrogel capsules: drug carriers, sub-compartmentalized microreactors, artificial organelles","volume":"6","author":"Zelikin","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/j100862a600","article-title":"The conformational transition of polymethacrylic acid in solution","volume":"71","author":"Mandel","year":"1967","journal-title":"J\u00a0Phys Chem"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib25","first-page":"1505","article-title":"Interpolymer complex between polyethylene oxide and polycarboxylic acid","volume":"13","author":"Ikawa","year":"1975","journal-title":"J\u00a0Polym Sci"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2007.01.037","article-title":"Hydrogen-bonded interpolymer complexes as materials for pharmaceutical applications","volume":"334","author":"Khutoryanskiy","year":"2007","journal-title":"Int J Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/ma102312y","article-title":"Molecular theory of weak polyelectrolyte gels: the role of pH and salt concentration","volume":"44","author":"Longo","year":"2011","journal-title":"Macromolecules"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.addr.2003.10.039","article-title":"Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules","volume":"56","author":"Yessine","year":"2004","journal-title":"Adv Drug Del Rev"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib29","first-page":"1835","article-title":"Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells","volume":"48","author":"Astier","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-3659(99)00114-5","article-title":"The design and synthesis of polymers for eukaryotic membrane disruption","volume":"61","author":"Murthy","year":"1999","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.biomaterials.2008.09.033","article-title":"The control of dendritic cell maturation by pH-sensitive polyion complex micelles","volume":"20","author":"Boudier","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00002030-199804000-00009","article-title":"Reduction of the viral load of HIV-1 after the intraperitoneal administration of dextrin 2-sulphate in patients with AIDS","volume":"12","author":"Shaunak","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib33","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1128\/AAC.43.10.2528","article-title":"The anti-Kaposi\u2019s sarcoma and anti-angiogenic activity of sulphated dextrins","volume":"43","author":"Thornton","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1208\/s12249-009-9348-5","article-title":"Sustained release tablets containing soluble polymethacrylates: comparison with tableted polymethacrylate IPEC polymers","volume":"11","author":"Obeidat","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.trstmh.2010.08.010","article-title":"An amphotericin B-based drug for treating Leishmania major infection","volume":"104","author":"Corware","year":"2010","journal-title":"Trans Royal Soc Trop Med Hyg"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.05.013","article-title":"Effect of aggregation state on the toxicity of different AmB preparations","volume":"361","author":"Espada","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nbt995","article-title":"Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation","volume":"22","author":"Shaunak","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib38","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0769-2625(87)80030-2","article-title":"Murine cutaneous leishmaniasis susceptibility correlates with differential expansion of helper T cell subsets","volume":"138","author":"Locksley","year":"1987","journal-title":"Ann Inst Pasteur\/Immunol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib39","first-page":"801","article-title":"Pathogen imposed skewing of mouse chemokine and cytokine expression at the infected tissue site","volume":"118","author":"Katzman","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jlb.52.2.135","article-title":"Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice","volume":"52","author":"Bell","year":"1992","journal-title":"J\u00a0Leucoc Biol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A\u00a0limiting dilution assay for quantifying L.\u00a0major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib42","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.4049\/jimmunol.165.5.2628","article-title":"An immuno-modulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB\/c mice infected with L.\u00a0major","volume":"165","author":"Tacchini-Cottier","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib43","first-page":"178","article-title":"Action of sodium deoxycholate on subcutaneous human tissue: local and systemic effects","volume":"33","author":"Odo","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib44","first-page":"529","article-title":"Tissue toxic effects of phosphatidylcholine\/deoxycholate after subcutaneous injection for fat dissolution in rats and a human volunteer","volume":"34","author":"Schuller-Petrovic","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0005-2736(97)00221-6","article-title":"The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs","volume":"1369","author":"Oussoren","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib46","first-page":"374","article-title":"Tissue reaction after intramuscular injection of liposomes in mice","volume":"30","author":"Kadir","year":"1992","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib47","unstructured":"Corware K. Modifying AmB for the treatment of cutaneous leishmaniasis. PhD thesis. Imperial College London; 2010."},{"key":"10.1016\/j.biomaterials.2011.07.021_bib48","unstructured":"Harris D. A homopolymer complex of AmB for the pharmacological treatment and immunotherapy of leishmaniasis. PhD thesis. University of London; 2006."},{"key":"10.1016\/j.biomaterials.2011.07.021_bib49","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.177.2.1250","article-title":"Lymph node resident rather than skin derived dendritic cells initiate specific T cell responses after L.\u00a0major infection","volume":"177","author":"Iezzi","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib50","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1590\/S0074-02762009000600017","article-title":"Histopathology of L.\u00a0major infection: revisiting L.\u00a0major histopathology in the ear dermis infection model","volume":"104","author":"Canguss\u00fa","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib51","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/IAI.68.1.288-293.2000","article-title":"Roles of endogenous IFN-\u03b3 and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis","volume":"68","author":"Murray","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib52","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to L.\u00a0donovani infection","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0042-6822(68)90215-8","article-title":"Interferon stimulating and in\u00a0vivo antiviral effects of various synthetic anionic polymers","volume":"35","author":"Merigan","year":"1968","journal-title":"Virology"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib54","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00002371-199108000-00007","article-title":"Induction of cytokine production from human monocytes stimulated with alginate","volume":"10","author":"Otterlei","year":"1991","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib55","doi-asserted-by":"crossref","first-page":"35489","DOI":"10.1074\/jbc.M201366200","article-title":"Involvement of TLR2 and TLR4 in cell activation by mannuronic acid polymers","volume":"277","author":"Flo","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nmat2614","article-title":"Emerging applications of stimuli-responsive polymer materials","volume":"9","author":"Cohen Stuart","year":"2010","journal-title":"Nat Mater"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib57","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.4049\/jimmunol.152.6.2930","article-title":"Intracellular infection by L.\u00a0donovani inhibits macrophage apoptosis","volume":"152","author":"Moore","year":"1994","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib58","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1084\/jem.183.2.515","article-title":"Leishmania promastigotes selectively inhibit IL-12 induction in bone marrow derived macrophages from susceptible and resistant mice","volume":"183","author":"Carrera","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib59","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/(SICI)1521-4141(199804)28:04<1389::AID-IMMU1389>3.0.CO;2-1","article-title":"Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania infected cells","volume":"28","author":"Belkaid","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib60","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.4049\/jimmunol.166.5.3416","article-title":"General suppression of macrophage gene expression during L.\u00a0donovani infection","volume":"166","author":"Buates","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.cdd.4400952","article-title":"Programmed cell death in the unicellular protozoan parasite Leishmania","volume":"9","author":"Lee","year":"2002","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib62","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/IAI.70.2.498-503.2002","article-title":"Influence of parasite load on the ability of Th1 T-cells to control L.\u00a0major infection","volume":"70","author":"Hondowicz","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib63","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1128\/IAI.72.4.1920-1928.2004","article-title":"TLR4 contributes to efficient control of infection with the protozoan parasite L.\u00a0major","volume":"72","author":"Kropf","year":"2004","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.biomaterials.2011.07.021_bib64","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1371\/journal.pntd.0000034","article-title":"Optimization of topical therapy for L.\u00a0major localized cutaneous leishmaniasis using a reliable C57BL\/6 model","volume":"1","author":"Lecoeur","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib65","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.biomaterials.2007.12.048","article-title":"Dissolving microneedles for transdermal drug delivery","volume":"29","author":"Lee","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib66","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/adma.200701205","article-title":"Minimally invasive protein delivery with rapidly dissolving polymer microneedles","volume":"20","author":"Sullivan","year":"2008","journal-title":"Adv Mater"},{"key":"10.1016\/j.biomaterials.2011.07.021_bib67","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/smll.201001091","article-title":"Dissolving microneedle patch for transdermal delivery of human growth hormone","volume":"7","author":"Lee","year":"2011","journal-title":"Small"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961211007927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961211007927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:31:14Z","timestamp":1758900674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961211007927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":67,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0142961211007927"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2011.07.021","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accelerated healing of cutaneous leishmaniasis in non-healing BALB\/c mice using water soluble amphotericin B-polymethacrylic acid","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2011.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}